Our Vision
OUR VISION
Translational Research
Bridging lab to clinic
Nanocarriers
Smart delivery systems
Microfluidics & Organ-on-Chip
Simulating cancer microenvironments with precision flow
Organoids
Mimicking real tissues
Screening Platforms
From concept to readout
Advanced In Vitro Models
Next-gen tools to decode tumor complexity
Shaping the Future of 3D-Based Therapeutics against Cancer
Cancer remains one of the most prevalent and impactful diseases worldwide. For example, ach year, over 2 million new cases are diagnosed, with hundreds of thousands of lives lost despite decades of research and therapeutic progress. As a global health challenge, breast cancer has galvanized efforts across scientific, medical, and technological domains — leading to groundbreaking discoveries in genetics, imaging, targeted therapies, and early detection.
In recent years, we’ve entered an era of precision oncology. Molecular subtyping, predictive biomarkers, and targeted therapeutics have revolutionized cancer care. Yet, even amidst this progress, a critical bottleneck remains: the translation of promising laboratory findings into safe and effective clinical treatments. The stark reality is that 95% of oncology drugs fail during clinical trials, often because the preclinical models used to test them (such as traditional 2D cell cultures) do not adequately reflect the complexity of human disease.
At ZetaBio Group, we believe the future of cancer therapeutics lies in more physiologically relevant preclinical platforms, models that better capture the intricate architecture, signaling, and microenvironment of tumors. Organ-on-a-chip sstems and three-dimensional (3D) models, such as spheroids and organoids offer, this potential. By mimicking key features of in vivo tissues, these models allow us to observe drug responses with greater fidelity and nuance.
We are committed to leveraging these advanced cellular platforms, not just as passive testing grounds, but as interactive systems where novel nanodrugs and smart delivery vehicles can be evaluated, optimized, and understood. Our focus spans from drug formulation and encapsulation strategies to the behavior of these compounds within complex cellular environments. Through this, we aim to support the development of more selective, efficient, and personalized therapies for cancer.
Ultimately, ZetaBio Group aspires to be more than a project: to become a platform for scientific growth, where knowledge exchange, ethical collaboration, and experimental innovation converge. Through this journey, we hope not only to accelerate cancer research but also to build the foundations for a sustainable, mission-driven enterprise that nurtures discovery, talent, and impact.
Together, we shape what’s next.
- Co-authorship opportunities on high-impact articles
- Technical input in nanocarrier development and cell model selection
- Participation in project design, data interpretation, and manuscript writing
- Flexible collaboration schemes (remote or in-person)
Emergency Symptoms
Egestas phasellus hac proin fringilla dis sed etiam purus aenean sed ut neque, sed enim in mollis auctor turpis dapibus sit tristique et malesuada aliquet vitae sagittis sollicitudin dui lectus massa elementum.
- Trouble breathing
- Constant pain or pressure in your chest
- Bluish lips or face
- Sudden confusion
What we offer
Common Symptoms
Risus pulvinar aliquam ut nullam sapien quam aliquam sodales suspendisse maecenas libero cursus imperdiet scelerisque elementum faucibus ultricies eu eleifend vulputate molestie nunc ullamcorper vulputate semper in id sed habitasse ornare nisl
- Co-authorship opportunities on high-impact articles
- Technical input in nanocarrier development and cell model selection
- Participation in project design, data interpretation, and manuscript writing
- Flexible collaboration schemes (remote or in-person)
Emergency Symptoms
Egestas phasellus hac proin fringilla dis sed etiam purus aenean sed ut neque, sed enim in mollis auctor turpis dapibus sit tristique et malesuada aliquet vitae sagittis sollicitudin dui lectus massa elementum.
- Trouble breathing
- Constant pain or pressure in your chest
- Bluish lips or face
- Sudden confusion
What We’re Looking For
A leo, morbi tempus, maecenas egestas felis pretium eget semper orci molestie id et volutpat egestas fermentum facilisis vitae semper nunc nec, neque est:
- Cell biologists with experience in organoids, tumoroids, or 3D models
- Engineers and chemists interested in nanocarrier formulation
- Data analysts for integration and interpretation of screening results
- Industry professionals interested in early-stage translational partnerships
Risus pulvinar aliquam ut nullam sapien quam aliquam sodales suspendisse maecenas libero cursus imperdiet scelerisque elementum faucibus ultricies eu eleifend vulputate molestie nunc ullamcorper vulputate semper in id sed habitasse ornare nisl.
We welcome diverse expertise and levels of experience:
- Students & MSc graduates
- PhD candidates & Postdocs
- Faculty members
- Industry experts
- Independent researchers
- Consultants
02.
Biomedical Engineers & Biotechnologists
Create and refine organ-on-a-chip systems and microfluidic platforms.
They integrate engineering with biology to simulate tissue environments and improve in vitro models.
